<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": italic;} Open Forum Infect DisOpen Forum Infect DisofidOpen Forum" exact="Infectious" post="Diseases2328-8957Oxford University PressUS pmcid: 7545115 doi: 10.1093/ofid/ofaa348ofaa348 : Review"/>
 <result pre="PressUS pmcid: 7545115 doi: 10.1093/ofid/ofaa348ofaa348 : Review Articles: AcademicSubjects/MED00290 Human" exact="Immunodeficiency" post="Virus in the State of Texas of the United"/>
 <result pre="http://orcid.org/0000-0002-2075-3179AbbasUme L17HallmarkCamden J2McNeeseMarlene2HemmigeVagish3GatheJoseph4WilliamsVictoria5WolfBrandon6Rodriguez-BarradasMaria C1[1], Baylor College of MedicineUSA[2], Division of" exact="Disease" post="Prevention and Control, Houston Health DepartmentUSA[3], Montiofiore Medical CenterUSA[4],"/>
 <result pre="HIV Epidemic: A Plan for Americaâ€� aims to reduce human" exact="immunodeficiency" post="virus (HIV) incidence in the United States by at"/>
 <result pre="a landmark initiative on February 5, 2019, Ending the human" exact="immunodeficiency" post="virus/acquired immunodeficiency syndrome (HIV/AIDS) Epidemic (EHE) [1]. The overall"/>
 <result pre="initiative on February 5, 2019, Ending the human immunodeficiency virus/acquired" exact="immunodeficiency" post="syndrome (HIV/AIDS) Epidemic (EHE) [1]. The overall goal is"/>
 <result pre="on February 5, 2019, Ending the human immunodeficiency virus/acquired immunodeficiency" exact="syndrome" post="(HIV/AIDS) Epidemic (EHE) [1]. The overall goal is to"/>
 <result pre="5, 2019, Ending the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS)" exact="Epidemic" post="(EHE) [1]. The overall goal is to reduce new"/>
 <result pre="of people (persons) with HIV (PWH), 95% of whom have" exact="viral" post="suppression; and 50% of persons at increased risk for"/>
 <result pre="Rico, that accounted for more than 50% of new human" exact="immunodeficiency" post="virus (HIV) diagnoses during 2016 and 2017 are shown"/>
 <result pre="of HIV are shown in blue. Adapted from Centers for" exact="Disease" post="Control and Prevention. Ending the HIV epidemic. Available at:"/>
 <result pre="[3], 37 515 persons were newly diagnosed, who were disproportionately" exact="African" post="American and Hispanic/Latinx. Male-male sexual contact Â± injection drug"/>
 <result pre="37 515 persons were newly diagnosed, who were disproportionately African" exact="American" post="and Hispanic/Latinx. Male-male sexual contact Â± injection drug use"/>
 <result pre="rates were highest among 20- to 34-year-olds. This brings the" exact="total" post="number of PWH in the United States to an"/>
 <result pre="49% are retained in continuous care and just 53% have" exact="viral" post="suppression [5]. Consequently, approximately 38% of HIV transmission occurs"/>
 <result pre="who created and distributed a trifold flyer about sexually transmitted" exact="infections" post="(STIs) in gay bars during the 1960s [8]. Later,"/>
 <result pre="services [9]. In 1981, the first case of gay-related immune" exact="deficiency" post="disease ([GRID] currently, AIDS) was diagnosed in Houston, followed"/>
 <result pre="[9]. In 1981, the first case of gay-related immune deficiency" exact="disease" post="([GRID] currently, AIDS) was diagnosed in Houston, followed by"/>
 <result pre="published a supplement titled â€œSexually Transmitted Diseases,â€� focused on Kaposiâ€™s" exact="sarcoma" post="(KS). The supplement reported that 53 men with suspected"/>
 <result pre="sarcoma (KS). The supplement reported that 53 men with suspected" exact="immunodeficiency" post="were screened at The University of Texas MD Anderson"/>
 <result pre="immunodeficiency were screened at The University of Texas MD Anderson" exact="Cancer" post="Center (MDACC) and found to have cellular immunodeficiency and"/>
 <result pre="MD Anderson Cancer Center (MDACC) and found to have cellular" exact="immunodeficiency" post="and high risk of developing the â€œnew gay disease,â€�"/>
 <result pre="Peter Mansell and Guy Newell, physicians in the department of" exact="cancer" post="prevention, spearheaded AIDS prevention studies and public education efforts"/>
 <result pre="efforts [17]. Based on the prevailing healthcare needs and opportunities," exact="American" post="Medical International Inc. (AMI), a for-profit hospital corporation that"/>
 <result pre="Texas (UT) System and MDACC, the conversion of AMIâ€™s Citizens" exact="General" post="Hospital to a unique, freestanding, dedicated AIDS hospital [18]."/>
 <result pre="[19]. Thus, the nationâ€™s first AIDS hospital, the Institute for" exact="Immunological" post="Disorders, opened on August 1, 1986, under the leadership"/>
 <result pre="Adan Rios (clinical research) [20]. Grounded in MDACCâ€™s philosophy of" exact="cancer" post="care, the Institute pioneered the now established, outpatient model"/>
 <result pre="(~20 miles from inner city and MDACC); disrepute of Citizens" exact="General" post="Hospital; inadequate support from local community, private practitioners, and"/>
 <result pre="to enable ATEUâ€™s continued operation [22]. Therefore, MDACC returned the" exact="residual" post="grant funds ($4 million) to the NIH, leaving the"/>
 <result pre="investigational drugs, as 1 of 12 sites sponsored by the" exact="American" post="Foundation for AIDS Research ([amfAR] currently named The Foundation"/>
 <result pre="Martin Delaney [30], the founder of Project Inform, a national" exact="HIV/AIDS" post="organization for advocacy, treatment information, and public policy, attended"/>
 <result pre="1 of 6 cities awarded funds from the Centers of" exact="Disease" post="Control and Prevention for HIV prevention, including health education,"/>
 <result pre="United States including Texas (Figure 3). Figure 3. New human" exact="immunodeficiency" post="virus (HIV) diagnoses, persons with HIV (PWH), and deaths"/>
 <result pre="prevalence, Texas 2018. Available at: https://dshs.texas.gov/hivstd/reports/. Accessed 17 July 2020." exact="Epidemic" post="Maturation, Control Progress (1996â€&quot;2017) HIV-related morbidity and mortality started"/>
 <result pre="became apparent by 1996 that showed disproportionately high diagnoses among" exact="African" post="Americans nationally. In 1999 [35], name-based HIV diagnosis reporting"/>
 <result pre="urban emergency department [37]. In 2010, the first US National" exact="HIV/AIDS" post="Strategy [38] and the Joint United Nations Programme on"/>
 <result pre="2010, the first US National HIV/AIDS Strategy [38] and the" exact="Joint" post="United Nations Programme on HIV/AIDS â€œGetting to Zeroâ€� Strategy"/>
 <result pre="HIV/AIDS Strategy [38] and the Joint United Nations Programme on" exact="HIV/AIDS" post="â€œGetting to Zeroâ€� Strategy were created [39]. Subsequently, Houston"/>
 <result pre="consideration of bodily fluids as a deadly weapon because of" exact="HIV-positive" post="status [44]. Weeks v. State affirmed the conviction of"/>
 <result pre="prison guard, and imposed a life imprisonment sentence [45]. Current" exact="Epidemic" post="In 2019, Houston signed with the Fast Track Cities"/>
 <result pre="populous US county, and it is ethnically diverse, predominantly (60%)" exact="African" post="American and Hispanic/Latinx [47], and an HIV hot spot"/>
 <result pre="US county, and it is ethnically diverse, predominantly (60%) African" exact="American" post="and Hispanic/Latinx [47], and an HIV hot spot [1]."/>
 <result pre="while injection drug use contributed another 4%â€&quot;6% [47â€&quot;49]. Moreover, although" exact="HIV seropositivity" post="is no longer a threat to immigration status [50],"/>
 <result pre="reflected in Texas [48, 49]. New diagnoses have been relatively" exact="stable" post="(&amp;gt;4000 annually) for over a decade, with a modest"/>
 <result pre="2009 decreased among black heterosexual women (8.1% vs 10.9%), remained" exact="stable" post="among white MSM (14.3% vs 14.8%), but increased among"/>
 <result pre="urban areas of Texas [49]. More than half (61%) have" exact="acquired" post="HIV through male-male sexual contact, whereas heterosexual contact (23%),"/>
 <result pre="(73% vs 78.3%) and 3 (83.2% vs 86.8%) months is" exact="lower" post="[5]. The gaps in the national targets for HIV"/>
 <result pre="46%). Likewise, the percentage tested in the past year fell" exact="short" post="of the aggregate (14.5%; 95% CI, 14%â€&quot;14.9%) in all"/>
 <result pre="rapid and effective treatment after diagnosis and achievement of sustained" exact="viral" post="suppression. This is critical for several reasons: (1) ~80%"/>
 <result pre="plasma virus level is considered untransmittable (U=U) [61]; and (3)" exact="viral" post="suppression leads to reduced HIV-related morbidity and mortality [34]."/>
 <result pre="(76.1% vs 75.7%) and retention (58.2% vs 57.9%), although HIV" exact="viral" post="suppression is lower (62.1% vs 64.7% among PWH and"/>
 <result pre="and retention (58.2% vs 57.9%), although HIV viral suppression is" exact="lower" post="(62.1% vs 64.7% among PWH and 81.6% vs 85.4%"/>
 <result pre="among PWH and 81.6% vs 85.4% among persons with â‰¥1" exact="viral" post="load test) [5]. However, much more effort is required"/>
 <result pre="effort is required to achieve the ambitious target of 95%" exact="viral" post="suppression within 10 years in Texas and nationwide. Figure"/>
 <result pre="and nationwide. Figure 4. Texas and Harris County diagnosis-based human" exact="immunodeficiency" post="virus (HIV) care continuum, 2018. Data source [5]; HIV"/>
 <result pre="alive at year-end 2018; Met need = â‰¥1 CD4 or" exact="viral" post="load (VL) test during 2018; Retained in care ="/>
 <result pre="incomes below the poverty line [63]. Texas has 40 program-funded" exact="primary" post="care providers including Harris County, which has 8 [28]."/>
 <result pre="of Ryan White funding per PWH [64], which fell far" exact="lower" post="than the 6 cities reviewed in a similar time"/>
 <result pre="25- to 44-year-olds (43.4%) [4]. The overall coverage was even" exact="lower" post="in Texas, at 14.3% [4], where an estimated 13"/>
 <result pre="sequence data that can be analyzed to determine genetically similar" exact="viral" post="variants, infer transmission relationships, and identify growing clusters that"/>
 <result pre="months before HIV. None had used PrEP. Overall, 41% had" exact="viral" post="suppression within 6 months of HIV diagnosis, whereas 13%"/>
 <result pre="months of HIV diagnosis, whereas 13% had never had a" exact="viral" post="load test. High-risk sexual behavior, low PrEP availability, missed"/>
 <result pre="test. High-risk sexual behavior, low PrEP availability, missed cases of" exact="acute" post="HIV, and delayed viral suppression were associated with rapid"/>
 <result pre="low PrEP availability, missed cases of acute HIV, and delayed" exact="viral" post="suppression were associated with rapid growth of this cluster"/>
 <result pre="1199 292 1690 1177 371 No. of Estimated New HIV" exact="Infections" post="210a 210a 670 1200 310a 1400 1100 300a No."/>
 <result pre="015 26 790 Percentage of People with Diagnosed HIV and" exact="Viral" post="Suppression 59.3 55.9 60.6 61.5 82.4 62.8 61.8 63.0"/>
 <result pre="the HIV Epidemic; FQHC, federally qualified health centers; HIV, human" exact="immunodeficiency" post="virus; MAT, medication-assisted treatment; PrEP, pre-exposure prophylaxis; STI, sexually"/>
 <result pre="PrEP, pre-exposure prophylaxis; STI, sexually transmitted infection. aThe Centers for" exact="Disease" post="Control and Prevention indicates that this estimate should be"/>
 <result pre="who had indications for PrEP.â€� COVID-19 and HIV The coronavirus" exact="disease" post="2019 (COVID-19) pandemic due to severe acute respiratory syndrome"/>
 <result pre="HIV The coronavirus disease 2019 (COVID-19) pandemic due to severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emergent threat"/>
 <result pre="The coronavirus disease 2019 (COVID-19) pandemic due to severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is an emergent threat to"/>
 <result pre="coronavirus disease 2019 (COVID-19) pandemic due to severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is an emergent threat to EHE."/>
 <result pre="the United States. JAMA Â 2019; 321:844â€&quot;5.30730529 2.collab: Centers for" exact="Disease" post="Control and Prevention. Ending the HIV epidemic. Available at:"/>
 <result pre="Available at: https://www.cdc.gov/endhiv/index.html. Accessed 17 July 2020. 3.collab: Centers for" exact="Disease" post="Control and Prevention. HIV Surveillance Report, 2018 (Updated); vol"/>
 <result pre="JohnsonAS, HuangYA, et al. Â Vital signs: status of human" exact="immunodeficiency" post="virus testing, viral suppression, and HIV preexposure prophylaxisâ€&quot;United States,"/>
 <result pre="al. Â Vital signs: status of human immunodeficiency virus testing," exact="viral" post="suppression, and HIV preexposure prophylaxisâ€&quot;United States, 2013â€&quot;2018. MMWR Morb"/>
 <result pre="Mortal Wkly Rep Â 2019; 68: 117â€&quot;23. 5.collab: Centers for" exact="Disease" post="Control and Prevention. Monitoring selected national HIV prevention and"/>
 <result pre="Morb Mortal Wkly Rep Â 2019; 68:267â€&quot;72.30897075 7.collab: Centers for" exact="Disease" post="Control and Prevention. HIV in the Southen United States."/>
 <result pre="at: https://www.aidshelp.org/. Accessed 17 July 2020. 10.collab: McGovern Historical Center." exact="HIV/AIDS" post="Houston Collection. Available at: https://library.tmc.edu/mcgovern/conducting-research/finding-aids/hivaids-ic072/. Accessed 17 July 2020."/>
 <result pre="Accessed 17 July 2020. 12.ReubenJM, HershEM, MansellPW, et al. Â" exact="Immunological" post="characterization of homosexual males. Cancer Res Â 1983; 43:897â€&quot;904.6600216"/>
 <result pre="HershEM, MansellPW, et al. Â Immunological characterization of homosexual males." exact="Cancer" post="Res Â 1983; 43:897â€&quot;904.6600216 13.WorobeyM, WattsTD, McKayRA, et al."/>
 <result pre="al. Â 1970s and â€˜Patient 0â€™ HIV-1 genomes illuminate early" exact="HIV/AIDS" post="history in North America. Nature Â 2016; 539:98â€&quot;101.27783600 14.Screening"/>
 <result pre="Timeline of events in the history of Houstonâ€™s response to" exact="HIV/AIDS" post="1981â€&quot;2015. Available at: http://www.houstonlgbthistory.org/Houston80s/Misc/AIDS-Houston%20Response/AIDS-Houston%20Response.pdf. Accessed 17 July 2020. 16.collab:"/>
 <result pre="Available at: http://www.houstonlgbthistory.org/Houston80s/Misc/AIDS-Houston%20Response/AIDS-Houston%20Response.pdf. Accessed 17 July 2020. 16.collab: Centers for" exact="Disease" post="Control and Prevention. HIV and AIDS--United States, 1981â€&quot;2000. MMWR"/>
 <result pre="Research Medical Library, The University of Texas M. D. Anderson" exact="Cancer" post="Center; 2003. 18.SoRELLERUT looking at plans to establish AIDS"/>
 <result pre="of a T-lymphotropic retrovirus from a patient at risk for" exact="acquired immune deficiency syndrome" post="(AIDS). Science Â 1983; 220:868â€&quot;71.6189183 30.HutmanSMartin Delaney: another kind"/>
 <result pre="T-lymphotropic retrovirus from a patient at risk for acquired immune" exact="deficiency" post="syndrome (AIDS). Science Â 1983; 220:868â€&quot;71.6189183 30.HutmanSMartin Delaney: another"/>
 <result pre="retrovirus from a patient at risk for acquired immune deficiency" exact="syndrome" post="(AIDS). Science Â 1983; 220:868â€&quot;71.6189183 30.HutmanSMartin Delaney: another kind"/>
 <result pre="provide AIDS relief. Mod Healthc Â 1990; 20:3. 33.collab: Federal" exact="HIV/AIDS" post="Web Council, HIV.gov. A timeline of HIV and AIDS."/>
 <result pre="et al. Â Antiretroviral drugs for treatment and prevention of" exact="HIV infection" post="in adults: 2018 Recommendations of the International Antiviral Society-USA"/>
 <result pre="al. Â Antiretroviral drugs for treatment and prevention of HIV" exact="infection" post="in adults: 2018 Recommendations of the International Antiviral Society-USA"/>
 <result pre="Antiviral Society-USA Panel. JAMA Â 2018; 320:379â€&quot;96.30043070 35.collab: Centers for" exact="Disease" post="Control and Prevention. Available at: https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed 17 July"/>
 <result pre="Ann Emerg Med Â 2011; 58:S79â€&quot;84.21684414 38.The White House. National" exact="HIV/AIDS" post="Strategy for the United States. Available at: https://www.hivlawandpolicy.org/sites/default/files/NHAS%20strategy.pdf. Accessed"/>
 <result pre="17 July 2020. 39.collab: UNAIDS. Getting to zero: 2011â€&quot;2015 strategy" exact="Joint" post="United Nations Programme on HIV/AIDS (UNAIDS). Available at:http://www.unaids.org/sites/default/files/sub_landing/files/JC2034_UNAIDS_Strategy_en.pdf. Accessed"/>
 <result pre="Getting to zero: 2011â€&quot;2015 strategy Joint United Nations Programme on" exact="HIV/AIDS" post="(UNAIDS). Available at:http://www.unaids.org/sites/default/files/sub_landing/files/JC2034_UNAIDS_Strategy_en.pdf. Accessed 17 July 2020. 40.collab: Centers"/>
 <result pre="(UNAIDS). Available at:http://www.unaids.org/sites/default/files/sub_landing/files/JC2034_UNAIDS_Strategy_en.pdf. Accessed 17 July 2020. 40.collab: Centers for" exact="Disease" post="Control and Prevention. The enhanced comprehensive HIV prevention planning"/>
 <result pre="project. Available https://www.cdc.gov/hiv/research/demonstration/echpp/index.html. Accessed 17 July 2020. 41.collab: Centers for" exact="Disease" post="Control and Prevention. Project Pride. Available at: https://www.cdc.gov/hiv/research/demonstration/projectpride.html. Accessed"/>
 <result pre="Available at: https://www.cdc.gov/hiv/research/demonstration/projectpride.html. Accessed 17 July 2020. 42.collab: Centers for" exact="Disease" post="Control and Prevention. Project Conectate. Available at: https://www.latinosandhiv.org/docs/Dr%20Oster%20Clusters%20Latino%20HIV%20HCV%202018.pdf. Accessed"/>
 <result pre="17 July 2020. 47.collab: Houston Health Department HIV Surveillance Program." exact="HIV infection" post="in Houston: an epidemiological profile 2010â€&quot;2014. Houston, Texas Â"/>
 <result pre="July 2020. 47.collab: Houston Health Department HIV Surveillance Program. HIV" exact="infection" post="in Houston: an epidemiological profile 2010â€&quot;2014. Houston, Texas Â"/>
 <result pre="Institute, 2015. 53.MenaL, CrosbyRAPortrait of an epidemic: extremely high human" exact="immunodeficiency" post="virus prevalence and incidence among young black men having"/>
 <result pre="Morb Mortal Wkly Rep Â 2019; 68:561â€&quot;7. 60.collab: Centers for" exact="Disease" post="Control and Prevention. Understanding the HIV care continuum. Available"/>
 <result pre="Available at: https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf. Accessed 17 July 2020. 61.EisingerRW, DieffenbachCW, FauciASHIV" exact="viral" post="load and transmissibility of HIV infection: undetectable equals untransmittable."/>
 <result pre="undetectable equals untransmittable. JAMA Â 2019; 321:451â€&quot;2.30629090 62.collab: Centers for" exact="Disease" post="Control and Prevention. Understanding the HIV care continuum. Available"/>
 <result pre="Accessed 17 July 2020. 65.PanagiotoglouD, OldingM, EnnsB, et al.; collab:" exact="Localized" post="HIV Modeling Study GroupBuilding the case for localized approaches"/>
 <result pre="al.; collab: Localized HIV Modeling Study GroupBuilding the case for" exact="localized" post="approaches to HIV: structural conditions and health system capacity"/>
 <result pre="HIV: structural conditions and health system capacity to address the" exact="HIV/AIDS" post="epidemic in six US Cities. AIDS Behav Â 2018;"/>
 <result pre="Â Clinical impact and cost-effectiveness of genotype testing at human" exact="immunodeficiency" post="virus diagnosis in the United States. Clin Infect Dis"/>
 <result pre="transmission cluster in Texas [abstract]. Conference on Retroviruses and Opportunistic" exact="Infections" post="(Seattle, WA). 13-16 February 2017. 72.ChangC-H, BynumJPW, LurieJDGeographic expansion"/>
 <result pre="implicit bias, and long-lasting prevention interventions to end the domestic" exact="HIV/AIDS" post="epidemic. Am J Public Health Â 2019; 110:67â€&quot;8. 77.ElopreL,"/>
 <result pre="Available at: https://federalreporter.nih.gov. Accessed 17 July 2020. 79.collab: Centers for" exact="Disease" post="Control and Prevention. HIV Surveillance Data Tables (early release):"/>
 <result pre="(early release): Core indicators for monitoring the Ending the HIV" exact="Epidemic" post="initiative, data reported through December 2019. Available at: https://www.cdc.gov/hiv/library/reports/ehe-core-indicators/index.html."/>
 <result pre="Accessed 17 July 2020. 80.NosykB, ZangX, KrebsE, et al.; collab:" exact="Localized" post="HIV Modeling Study GroupEnding the HIV epidemic in the"/>
 <result pre="2019; 23:557â€&quot;63.30796638 82.NosykB, ZangX, KrebsE, et al. Â Ending the" exact="Epidemic" post="in America will not happen if the status quo"/>
 <result pre="happen if the status quo continues: modeled projections for human" exact="immunodeficiency" post="virus incidence in 6 US Cities. Clin Infect Dis"/>
 <result pre="al. Â The clinical and economic impact of attaining National" exact="HIV/AIDS" post="Strategy Treatment Targets in the United States. J Infect"/>
 <result pre="MorenoS, et al. Â Incidence and severity of COVID-19 in" exact="HIV-positive" post="persons receiving antiretroviral therapy: a cohort study. Ann Intern"/>
</results>
